BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 33068827)

  • 1. A spraying applicator device is not required for efficacy of a live intranasal respiratory vaccine in young calves, which improves user convenience.
    Nuijten P; van der Loop J; van Rooij M; Makoschey B; Vertenten G
    Vet Immunol Immunopathol; 2020 Dec; 230():110130. PubMed ID: 33068827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of two intranasal vaccines for the control of bovine respiratory disease in newborn beef calves: A randomized non-inferiority multicentre field trial.
    Masset N; Meurens F; Marie M; Lesage P; Lehébel A; Brisseau N; Assié S
    Vet J; 2020 Sep; 263():105532. PubMed ID: 32928493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the immune response following subcutaneous versus intranasal modified-live virus booster vaccination against bovine respiratory disease in pre-weaning beef calves that had received primary vaccination by the intranasal route.
    Palomares RA; Bittar JHJ; Woolums AR; Hoyos-Jaramillo A; Hurley DJ; Saliki JT; Ferrer MS; Bullington AC; Rodriguez A; Murray T; Thoresen M; Jones K; Stoskute A
    Vet Immunol Immunopathol; 2021 Jul; 237():110254. PubMed ID: 34034143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Virus detection by PCR following vaccination of naive calves with intranasal or injectable multivalent modified-live viral vaccines.
    Walz PH; Newcomer BW; Riddell KP; Scruggs DW; Cortese VS
    J Vet Diagn Invest; 2017 Sep; 29(5):628-635. PubMed ID: 28545321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and microbiological effects in high-risk beef calves administered intranasal or parenteral modified-live virus vaccines.
    Powledge SA; McAtee TB; Woolums AR; Robin Falkner T; Groves JT; Thoresen M; Valeris-Chacin R; Richeson JT
    J Anim Sci; 2022 Nov; 100(11):. PubMed ID: 35926833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of a modified live intranasal bovine respiratory syncytial virus vaccine in 3-week-old calves experimentally challenged with BRSV.
    Vangeel I; Antonis AF; Fluess M; Riegler L; Peters AR; Harmeyer SS
    Vet J; 2007 Nov; 174(3):627-35. PubMed ID: 17169592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of an intranasal modified live bovine respiratory syncytial virus and temperature-sensitive parainfluenza type 3 virus vaccine in 3-week-old calves experimentally challenged with PI3V.
    Vangeel I; Ioannou F; Riegler L; Salt JS; Harmeyer SS
    Vet J; 2009 Jan; 179(1):101-8. PubMed ID: 17931918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Duration of immunity of a quadrivalent vaccine against respiratory diseases caused by BHV-1, PI3V, BVDV, and BRSV in experimentally infected calves.
    Peters AR; Thevasagayam SJ; Wiseman A; Salt JS
    Prev Vet Med; 2004 Dec; 66(1-4):63-77. PubMed ID: 15579335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of calf age and administration route of initial multivalent modified-live virus vaccine on humoral and cell-mediated immune responses following subsequent administration of a booster vaccination at weaning in beef calves.
    Woolums AR; Berghaus RD; Berghaus LJ; Ellis RW; Pence ME; Saliki JT; Hurley KA; Galland KL; Burdett WW; Nordstrom ST; Hurley DJ
    Am J Vet Res; 2013 Feb; 74(2):343-54. PubMed ID: 23363363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NASYM, a live intranasal vaccine, protects young calves from bovine respiratory syncytial virus in the presence of maternal antibodies.
    Marzo E; Montbrau C; Moreno MC; Roca M; Sitjà M; March R; Gow S; Lacoste S; Ellis J
    Vet Rec; 2021 Jun; 188(11):e83. PubMed ID: 33818796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response to experimentally induced infection with bovine respiratory syncytial virus following intranasal vaccination of seropositive and seronegative calves.
    Ellis JA; Gow SP; Goji N
    J Am Vet Med Assoc; 2010 May; 236(9):991-9. PubMed ID: 20433400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Response of calves to challenge exposure with virulent bovine respiratory syncytial virus following intranasal administration of vaccines formulated for parenteral administration.
    Ellis J; Gow S; West K; Waldner C; Rhodes C; Mutwiri G; Rosenberg H
    J Am Vet Med Assoc; 2007 Jan; 230(2):233-43. PubMed ID: 17223757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of injectable trace minerals on humoral and cell-mediated immune responses to Bovine viral diarrhea virus, Bovine herpes virus 1 and Bovine respiratory syncytial virus following administration of a modified-live virus vaccine in dairy calves.
    Palomares RA; Hurley DJ; Bittar JH; Saliki JT; Woolums AR; Moliere F; Havenga LJ; Norton NA; Clifton SJ; Sigmund AB; Barber CE; Berger ML; Clark MJ; Fratto MA
    Vet Immunol Immunopathol; 2016 Oct; 178():88-98. PubMed ID: 27496747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of bovine vaccines against respiratory viruses administered either intranasal or intramuscular on broncho-alveolar fluid cells of heifers.
    Rossi PS; Mattei RI; Schllemer NR; Thomaz GR; Antunes AV; Virmond MP; Taube MJ; Bertagnon HG
    Vet Q; 2021 Dec; 41(1):97-106. PubMed ID: 33375918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative efficacy of modified-live and inactivated vaccines in boosting responses to bovine respiratory syncytial virus following neonatal mucosal priming of beef calves.
    Ellis J; Gow S; Berenik A; Lacoste S; Erickson N
    Can Vet J; 2018 Dec; 59(12):1311-1319. PubMed ID: 30532289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of a quadrivalent vaccine against respiratory diseases caused by BHV-1, PI3V, BVDV and BRSV in experimentally infected calves.
    Salt JS; Thevasagayam SJ; Wiseman A; Peters AR
    Vet J; 2007 Nov; 174(3):616-26. PubMed ID: 17276108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparing the immune response to a novel intranasal nanoparticle PLGA vaccine and a commercial BPI3V vaccine in dairy calves.
    Mansoor F; Earley B; Cassidy JP; Markey B; Doherty S; Welsh MD
    BMC Vet Res; 2015 Aug; 11():220. PubMed ID: 26293453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Duration of immunity to experimental infection with bovine respiratory syncytial virus following intranasal vaccination of young passively immune calves.
    Ellis JA; Gow SP; Mahan S; Leyh R
    J Am Vet Med Assoc; 2013 Dec; 243(11):1602-8. PubMed ID: 24261811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intranasal booster vaccination of beef steers reduces clinical signs following experimental coinfection with BRSV and BHV-1 without reducing shedding of BRD-associated bacteria.
    Martínez DA; Chamorro MF; Passler T; Huber L; Falkenberg S; Walz PH; Thoresen M; Raithel G; Silvis S; Dimitrov KM; Stockler R; Woolums AR
    Am J Vet Res; 2024 May; 85(5):. PubMed ID: 38422620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity of a modified-live virus vaccine against bovine viral diarrhea virus types 1 and 2, infectious bovine rhinotracheitis virus, bovine parainfluenza-3 virus, and bovine respiratory syncytial virus when administered intranasally in young calves.
    Xue W; Ellis J; Mattick D; Smith L; Brady R; Trigo E
    Vaccine; 2010 May; 28(22):3784-92. PubMed ID: 20381643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.